Hypertension, Vol 14, 385-395, Copyright © 1989 by American Heart Association
GL Barrett, TO Morgan, M Smith, D Alcorn and P Aldred
We have investigated the relative importance of renal renin stores and de
novo synthesis during stimulation of renin secretion and the role of
transcription and posttranscriptional factors in providing increased
synthesis of renin. When enalapril was administered to previously untreated
mice, plasma renin concentration increased 40-fold within 1.5 hours, and
remained at a high level for the 8 days of the experiment. Renal renin
decreased by 82% after 24 hours and thereafter increased to levels higher
than controls. Calculations of renin turnover, based on data for the rate
of metabolism of renin in plasma, indicated that most of the renin released
in the first 24 hours could be accounted for by the decrease in renal renin
stores, indicating that de novo synthesis played only a minor role. After
24 hours, however, when both plasma renin concentration and renal renin
increased, the calculated rate of renin synthesis increased to nearly 40
times the rate in controls. When enalapril was administered to mice that
had been depleted of plasma and renal renin by chronic sodium loading,
plasma renin concentration increased markedly within 1.5 hours, but to only
half the level achieved in the previously untreated mice. No decrease in
renal renin occurred, suggesting that the renal renin remaining after
chronic sodium loading was not available for release. Renal renin messenger
RNA increased 4.5-fold after 6 hours, and after 8 days had increased to 5.0
times the level at day 0. The increase in calculated rate of renin
synthesis was maximal between 5 and 8 days, when it was 54 times greater
than at day 0. During enalapril treatment, there were marked increases in
the granulation of the juxtaglomerular cells and in the amount of rough
endoplasmic reticulum and Golgi apparatus they contained. These results
suggest that posttranscriptional factors play a major role in determining
the rate of renin synthesis.
ARTICLES
Effect of converting enzyme inhibition on renin synthesis and secretion in mice
Department of Physiology, University of Melbourne, Parkville, Australia.
This article has been cited by other articles:
![]() |
E. Abro, C. D Griffiths, T. O Morgan, and L. M. Delbridge Regression of cardiac hypertrophy in the SHR by combined renin-angiotensin system blockade and dietary sodium restriction Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S148 - S153. [Abstract] [PDF] |
||||
![]() |
C. Marie, C. Mossiat, C. Gros, J.-C. Schwartz, J.-M. Lecomte, and J. Bralet Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction Cardiovasc Res, March 1, 1999; 41(3): 544 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yan, L. Hu, R. Chen, J. E. Sealey, J. H. Laragh, and D. F. Catanzaro Appropriate Regulation of Human Renin Gene Expression and Secretion in 45-kb Human Renin Transgenic Mice Hypertension, August 1, 1998; 32(2): 205 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. N. Serneri, M. Boddi, M. Coppo, T. Chechi, N. Zarone, M. Moira, L. Poggesi, M. Margheri, and I. Simonetti Evidence for the Existence of a Functional Cardiac Renin-Angiotensin System in Humans Circulation, October 15, 1996; 94(8): 1886 - 1893. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |